RAYVOW Logo (EUIPO, 06/12/2020)
EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark RAYVOW was filed as Figurative mark on 06/12/2020 at the European Union Intellectual Property Office.
It was registered as a trademark on 12/22/2020.
The current status of the mark is "Trademark registered".
Logodesign (Wiener Klassifikation)
#Two lines or bands #Curved lines or bands (except A 26.11.13) #Other lines or bands #Letters or numerals forming some other geometrical figure #Green #Blue
| Trademark form | Figurative mark |
| File reference | 018252745 |
| Application date | June 12, 2020 |
| Publication date | September 11, 2020 |
| Entry date | December 22, 2020 |
| Expiration date | June 12, 2030 |
Trademark owner
Lilly Corporate Center
46285 Indianapolis,
US
46285 Indianapolis,
US
Trademark representatives
Widenmayerstr. 10
80538 München
DE
goods and services
5
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment, diagnosis and/or prevention of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders; pharmaceutical preparations for the treatment, diagnosis and/or prevention of cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders; pharmaceutical preparations for the treatment, diagnosis and/or prevention of fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders; pharmaceutical preparations for the treatment, diagnosis and/or prevention of migraines, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases; Diagnostic agents, preparations and substances for medical purposes; diagnostic scanning agents for medical use, namely, diagnostic scanning agents for in vivo use; radiopharmaceutical diagnostic preparations for medical use; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative amyloid diseases; pharmaceutical preparations
44
Medical information services in the field of pain and migraine
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| January 5, 2021 | Change Representative, Published |
ID: 11018252745